151 related articles for article (PubMed ID: 38709988)
21.
Qi XP; Jin BY; Li PF; Wang S; Zhao YH; Cao ZL; Yu XH; Cheng J; Fang XD; Zhao JQ
Thyroid; 2019 Oct; 29(10):1447-1456. PubMed ID: 31364476
[No Abstract] [Full Text] [Related]
22. Medullary Thyroid Carcinoma Associated with Germline RET
Xu JY; Grubbs EG; Waguespack SG; Jimenez C; Gagel RF; Sosa JA; Sellin RV; Dadu R; Hu MI; Trotter CS; Jackson M; Rich TA; Hyde SM; Sherman SI; Cote GJ
Thyroid; 2016 Dec; 26(12):1744-1751. PubMed ID: 27673361
[TBL] [Abstract][Full Text] [Related]
23. Management of Medullary Thyroid Cancer.
Viola D; Elisei R
Endocrinol Metab Clin North Am; 2019 Mar; 48(1):285-301. PubMed ID: 30717909
[TBL] [Abstract][Full Text] [Related]
24. Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective.
Brauckhoff M; Machens A; Lorenz K; Bjøro T; Varhaug JE; Dralle H
Ann Surg; 2014 Apr; 259(4):800-6. PubMed ID: 23979292
[TBL] [Abstract][Full Text] [Related]
25. A comprehensive review on MEN2B.
Castinetti F; Moley J; Mulligan L; Waguespack SG
Endocr Relat Cancer; 2018 Feb; 25(2):T29-T39. PubMed ID: 28698189
[TBL] [Abstract][Full Text] [Related]
26. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
Jin LX; Moley JF
Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
[TBL] [Abstract][Full Text] [Related]
27. Timing and extent of thyroid surgery for gene carriers of hereditary C cell disease--a consensus statement of the European Society of Endocrine Surgeons (ESES).
Niederle B; Sebag F; Brauckhoff M
Langenbecks Arch Surg; 2014 Feb; 399(2):185-97. PubMed ID: 24297502
[TBL] [Abstract][Full Text] [Related]
28. Mild to moderate increase of serum calcitonin levels only in presence of large medullary thyroid cancer deposits.
Pelizzo MR; Torresan F; Da Roit A; Merante Boschin I; Chondrogiannis S; Rampin L; Colletti PM; Vinjamury S; Perkins AJ; Rubello D
Rev Esp Med Nucl Imagen Mol; 2015; 34(6):378-82. PubMed ID: 26420439
[TBL] [Abstract][Full Text] [Related]
29. [Precision medicine in endocrinology exemplified by medullary thyroid cancer].
Brandenburg T; Machlah YM; Führer D
Inn Med (Heidelb); 2024 Mar; 65(3):202-210. PubMed ID: 38231404
[TBL] [Abstract][Full Text] [Related]
30. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
[TBL] [Abstract][Full Text] [Related]
31. Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.
Komminoth P
Verh Dtsch Ges Pathol; 1995; 79():L-LV. PubMed ID: 8600671
[TBL] [Abstract][Full Text] [Related]
32. A Novel Double
Mathew A; Latteyer S; Frank-Raue K; Moeller LC; Zwanziger D; Mengel M; Führer D; Tiedje V
Thyroid; 2021 Feb; 31(2):327-329. PubMed ID: 32546069
[No Abstract] [Full Text] [Related]
33. Revisiting the genotype-phenotype correlation in children with medullary thyroid carcinoma: A report from the GPOH-MET registry.
Kuhlen M; Frühwald MC; Dunstheimer DPA; Vorwerk P; Redlich A
Pediatr Blood Cancer; 2020 Apr; 67(4):e28171. PubMed ID: 31925938
[TBL] [Abstract][Full Text] [Related]
34. Medullary thyroid carcinoma in children: current state of the art and future perspectives.
Kiriakopoulos A; Dimopoulou A; Nastos C; Dimopoulou D; Dimopoulou K; Menenakos E; Zavras N
J Pediatr Endocrinol Metab; 2022 Jan; 35(1):1-10. PubMed ID: 34592078
[TBL] [Abstract][Full Text] [Related]
35. Prophylactic thyroidectomy in multiple endocrine neoplasia 2 (MEN2) patients with the C634Y mutation: A long-term follow-up in a large single-center cohort.
Febrero B; Rodríguez JM; Ríos A; Segura P; Pérez-Sánchez B; Torregrosa N; Hernández AM; Parrilla P
Eur J Surg Oncol; 2019 Apr; 45(4):625-630. PubMed ID: 30366876
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines.
Thomas CM; Asa SL; Ezzat S; Sawka AM; Goldstein D
Curr Oncol; 2019 Oct; 26(5):338-344. PubMed ID: 31708652
[TBL] [Abstract][Full Text] [Related]
37. Update on the Treatment of Medullary Thyroid Carcinoma in Patients with Multiple Endocrine Neoplasia Type 2.
Ilanchezhian M; Khan S; Okafor C; Glod J; Del Rivero J
Horm Metab Res; 2020 Aug; 52(8):588-597. PubMed ID: 32299110
[TBL] [Abstract][Full Text] [Related]
38. Medullary thyroid carcinoma and multiple endocrine neoplasia type 2.
Takami H
Endocr Pathol; 2003; 14(2):123-31. PubMed ID: 12858002
[TBL] [Abstract][Full Text] [Related]
39. Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study.
Castinetti F; Waguespack SG; Machens A; Uchino S; Hasse-Lazar K; Sanso G; Else T; Dvorakova S; Qi XP; Elisei R; Maia AL; Glod J; Lourenço DM; Valdes N; Mathiesen J; Wohllk N; Bandgar TR; Drui D; Korbonits M; Druce MR; Brain C; Kurzawinski T; Patocs A; Bugalho MJ; Lacroix A; Caron P; Fainstein-Day P; Borson Chazot F; Klein M; Links TP; Letizia C; Fugazzola L; Chabre O; Canu L; Cohen R; Tabarin A; Spehar Uroic A; Maiter D; Laboureau S; Mian C; Peczkowska M; Sebag F; Brue T; Mirebeau-Prunier D; Leclerc L; Bausch B; Berdelou A; Sukurai A; Vlcek P; Krajewska J; Barontini M; Vaz Ferreira Vargas C; Valerio L; Ceolin L; Akshintala S; Hoff A; Godballe C; Jarzab B; Jimenez C; Eng C; Imai T; Schlumberger M; Grubbs E; Dralle H; Neumann HP; Baudin E
Lancet Diabetes Endocrinol; 2019 Mar; 7(3):213-220. PubMed ID: 30660595
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
